Derrick Rossi, PhD
Associate Professor at Harvard University, CEO of Convelo Therapeutics
2010 NYSCF – Robertson Stem Cell Investigator Alumnus
PhD, University of Helsinki, Finland
Postdoctoral Training, Stanford University
Bio
Dr. Rossi is an Associate Professor at Harvard Medical School, where he works on programming cells into clinically useful cell types including liver cells, blood cells, and induced pluripotent stem cells. In particular, he is interested in understanding the mechanisms enabling self-renewal and multi-potency of blood stem cells. He is also CEO of Convelo Therapeutics, a biotech company developing a new class of medicines that unlock the regenerative capacity of the central nervous system. He completed his postdoctoral studies at Stanford University.
External Links
Research Area
Mentioned In
- Updates on the NYSCF Community’s Fight Against COVID-19
- The Science of Startups: Drs. Derrick Rossi and Paul Tesar Discuss How Their Biotechs Are Bringing Stem Cell Research to Patients
- Dr. Paul Tesar Launches New Company Aimed at Treating Neurological Disease
- NYSCF Innovator Improves CRISPR Genome Repair
- NYSCF - Robertson Investigator Finds a Promising Strategy Against HIV